A number of Nobel Laureates in economics have been grappling with the problem of research, development, and transfer of clean technologies in order to tackle the climate crisis. Joseph Stiglitz has been investigating how intellectual property laws could be recalibrated…
October 2019 By Matthew Rimmer*, Professor in Intellectual Property and Innovation Law at the Faculty of Law in the Queensland University of Technology (QUT), Brisbane, Australia 3D printing is a field of technology that relies upon additive manufacturing (as opposed to traditional…
PIJIP, in its role as chair of the Global Expert Network on Copyright User Rights, will sponsor two events in Brazil to discuss how copyright can promote rights to access educational and research materials. The meetings are being planned at a time when these issues are being discussed in an agenda item of the World Intellectual Property Organization Standing Committee on Copyright and Related Rights. Brazil has also announced a copyright reform process. Details on the meetings, each of which is open to the public, are detailed below.
The 39th Standing Committee on Copyright and Related Rights (SCCR) of the World Intellectual Property Organization (WIPO) concluded with measured progress on the agenda to discuss international instruments on limitations and exceptions amid increasing controversy over the management of the Committee.
The following statement was made by Deputy Director General Sylvie Forbin at the Standing Committee on Copyright and Related Rights summarizing the conclusions from the international conference on limitations and exceptions held October 18-19 in Geneva, Switzerland. The text below is a transcript of an oral presentation and may contain small errors and incomplete syntax given the mode of presentation. A fuller written report on the conference and regional seminars will be published by the Secretariat two months before the 40th meeting of the SCCR. The date for the 40th SCCR has not been set.
[R.F. Beall, L. Hardcastle, F. Clement and A. Hollis] Abstract: Canada recently entered into two multinational trade agreements (i.e., the Canada, United States, and Mexico Trade Agreement; and the Comprehensive Economic and Trade Agreement with the European Union). The resulting federal policy changes will prolong periods of market protection afforded to eligible brand-name prescription drugs by extending competition-blocking patent and data exclusivity terms. While previous studies have analysed these two policy changes in isolation, it remains unknown what the total combined impact will be in a typical year.